Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - MIT Holding, Inc.Financial_Report.xls
10-Q - MIT Holding, Inc.form10q.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R34.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R60.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R42.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R23.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R59.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R45.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R25.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R54.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R47.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R27.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R32.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R31.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R28.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R55.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R33.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R30.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R49.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R37.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R44.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R26.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R41.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R43.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R40.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R46.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R51.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R57.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R48.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R56.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R35.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R38.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R29.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R58.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R53.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R50.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R36.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R52.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R39.htm
XML - IDEA: XBRL DOCUMENT - MIT Holding, Inc.R18.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) - MIT Holding, Inc.ex31-2.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - MIT Holding, Inc.ex32-2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) - MIT Holding, Inc.ex31-1.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - MIT Holding, Inc.ex32-1.htm
v2.4.0.6
Operating Segments
9 Months Ended
Sep. 30, 2012
Segment Reporting [Abstract]  
Operating Segments

NOTE M – OPERATING SEGMENTS

 

The Company has four principal operating segments, which are as follows:

 

  Medical Infusion Technologies-“MIT”
  MIT International / Provector
  Durable Medical Equipment - “DME”
  MIT Ambulatory Care Center -“Ambulatory Care”

 

“MIT” is a provider of intravenous therapies to patients at their home, at a designated facility. MIT’s primary product lines are centered upon infusion therapy.

 

“International / Provector” is the division responsible for the marketing and distribution of Provector on a worldwide basis for international sales only.

 

“DME” carries a variety of durable medical equipment and supplies.

 

“Ambulatory Care” administers the intravenous therapies to patients in the Company’s facility.

 

The following tables show the summarized financial information of the Company’s reportable segments at SEPTEMBER 30, 2012 and 2011 and for the nine months ended:

 

    Medical                                
    Infusion     International/     Ambulatory                    
    - MIT     Provector     Care     DME     Wholesale     Combined  
2012                                    
Revenue   $ 1,381,898     $ -     $ 711,343     $ 310,355     $ 451,162     $ 2,854,758  
Income (loss) from operations     (1,051,379 )     -       173,479       8,796       26,166       (842,937 )
Depreciation and amortization     29,997       -       -       -               29,997  
Assets   $ 729,855       -     $ 114,622     $ 138,192             $ 982,670  
                                                 
2011                                                
Revenue   $ 1,846,175     $ 200,000     $ 2,414,311     $ 262,339     $       $ 4,722,825  
Income (loss) from operations     (1,169,217 )     (193,946 )     1,077,188       33,981               (251,993
Depreciation and amortization     29,997       -       -       -               29,997  
Assets   $ 4,546,132       -     $ 473,744     $ 87,150             $ 5,107,026